SOLACI

idioma

15 Must read articles

SOLACI
MEMBERS
- Become a Member
- Professionals Directory
CONGRESS
View all
- SOLACI-SBHCI 23 - 01 / 08 / 2023
- SOLACI-SOCIME 22 - 03 / 08 / 2022
- SOLACI-CACI 21 - 13 / 09 / 2021
- SOLACI-SBHCI 2019 - 17 / 04 / 2019
- SOLACI-SOCIME’18 - 12 / 04 / 2018
View all
- ACC 2024 - 09 / 04 / 2024
- AHA 2023 - 13 / 11 / 2023
- TCT 2023 - 24 / 10 / 2023
- ESC 2023 - 28 / 08 / 2023
- EuroPCR 2023 - 17 / 05 / 2023
View all
- EuroPCR 2024 – from May 14th to 17th in Paris - 05 / 04 / 2024
- Cli-C Global 2024 - 21 / 02 / 2024
- Structural Summit 2024 – Deadline Extended: One More Week to Submit Your Work - 05 / 02 / 2024
- Structural Summit 2024: Disruptive Innovations, Complex Interventions - 16 / 01 / 2024
- Cardiointerv 2023 Soon to Be Held - 11 / 11 / 2023
View all
View all
SESSIONS
- About Regional Sessions
- Sessions
View all
- Peru Sessions 2023 - 27 / 10 / 2023
- Dominican Republic Sessions 2023 – All You Should Know - 06 / 09 / 2023
- Colombia Sessions 2022 - 18 / 08 / 2022
- Paraguay 2022 Sessions - 01 / 04 / 2022
- Mexico Sessions 2021 - 02 / 12 / 2021
View all
ProEducar
SOLACI Research
PUBLICATIONS
View all
View all
- Angiografia coronaria cuantitativa: métodos y aplicaciones - 28 / 09 / 2015
- Ultrasonido Intravascular - 28 / 09 / 2015
- Placa vulnerable: definición, diagnóstico y tratamiento. - 28 / 09 / 2015
- Stents coronarios: indicaciones actuales - 28 / 09 / 2015
- Trombosis del stent. Antes y después de los stents farmacológicos - 28 / 09 / 2015
View all
- JSHD | JOURNAL OF STRUCTURAL HEART DISEASE - 03 / 12 / 2019
- EuroIntervention. Official Publication of EuroPCR & EAPCI - 29 / 11 / 2019
- JACC | Journal of the American College of Cardiology - 28 / 11 / 2019
- CCI | Catheterization and Cardiovascular Interventions - 27 / 11 / 2019
- REC | Interventional Cardiology - 26 / 11 / 2019
View all
NURSES AND TECHNICIANS
Contact

LATEST NEWS

ACC 2024 | ORBITA-COSMIC
ACC 2024 | IVUS-DCB
ACC 2024 | REDUCE AMI: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
ACC 2024 | SMART Trial: Self-Expanding or Balloon-Expandable TAVR in Patients with Small Aortic Annulus
ACC 2024 | DEDICATE Trial: Transcatheter or Surgical Treatment of Aortic Valve Stenosis
ACC 2024 | PREVENT Study
Temporal Trends in Transcatheter Aortic Valve Replacement for Isolated Severe Aortic Stenosis

File
Heart Disease
Peripheral vascular disease
Pharmacology
Structural heart disease
All the articles

EVOLVE II TRIAL: SYNERGY everolimus-eluting stent is not inferior to Promus Element

Day 4

24 / 06 / 2015

Descargar (PDF, Unknown)

Dean J. Kereiakes
2014-11-20

Cancel reply

Your Name *

Your Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Related Articles

LIFELINE STEMI ACCELERATOR TRIAL: Improving the duration of treatment of AMI can save even more lives

Long-term outcome of a biodegradable polymer compared with durable polymers in drug eluting and conventional stents – Main results of a prospective randomized study

EVOLVE II TRIAL: SYNERGY everolimus-eluting stent is not inferior to Promus Element

AVOID: Randomized controlled trial of oxygen therapy in AMI with ST-segment elevation: Air versus oxygen in myocardial infarction

This may interest you

ACC 2024

ACC 2024 | ORBITA-COSMIC

17.04.2024

ACC 2024

ACC 2024 | IVUS-DCB

17.04.2024

ACC 2024

ACC 2024 | REDUCE AMI: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

16.04.2024

The Visible Heart Lab

04/23 – SOLACI-Medtronic Webinar | The Visible Heart Lab. Register now

16.04.2024

ACC 2024

ACC 2024 | SMART Trial: Self-Expanding or Balloon-Expandable TAVR in Patients with Small Aortic Annulus

12.04.2024

ACC 2024

ACC 2024 | DEDICATE Trial: Transcatheter or Surgical Treatment of Aortic Valve Stenosis

11.04.2024

ACC 2024

ACC 2024 | PREVENT Study

11.04.2024

Sistema EVOQUE: reemplazo tricuspídeo transcatéter, resultados al año

Temporal Trends in Transcatheter Aortic Valve Replacement for Isolated Severe Aortic Stenosis

11.04.2024

ACC 2024

ACC 2024 | DanGer-Shock Trial

10.04.2024

ACC 2024

ACC 2024 | ULTIMATE-DAPT Trial

10.04.2024

ACC 2024

ACC 2024 | RELIEVE-HF

10.04.2024

ACC 2024

ACC 2024

09.04.2024

This may interest you

ACC 2024

ACC 2024 | ORBITA-COSMIC

ACC 2024

ACC 2024 | IVUS-DCB

ACC 2024

ACC 2024 | REDUCE AMI: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

The Visible Heart Lab

04/23 – SOLACI-Medtronic Webinar | The Visible Heart Lab. Register now

ACC 2024

ACC 2024 | SMART Trial: Self-Expanding or Balloon-Expandable TAVR in Patients with Small Aortic Annulus

MOST READ POSTS

When and How to Switch Dual Antiplatelet Therapies
ACC 2024 | DEDICATE Trial: Transcatheter or Surgical Treatment of Aortic Valve Stenosis
ACC 2024 | DanGer-Shock Trial
“Troponinitis” or “Troponinemia”: Terms that Trivialize Troponin Elevation Without a Specified Diagnosis
Challenging Borders and Advancing Together: Women at the Forefront of Hemodynamics – Watch again our webinar

LATEST TWEETS

SOLACI Follow

Somos la Sociedad Latinoamericana de Cardiología Intervencionista y bregamos por promover el intervencionismo cardiovascular en América Latina y el Caribe.

SOLACI @solaci3 ·

⭐ Nuevo artículo en https://solaci.org
▶ TAVI en los diferentes tipos de estenosis aórtica
▶ Por el Dr. Carlos Fava
https://buff.ly/3PRvuIy

Reply on Twitter 1776037066704367937 Retweet on Twitter 1776037066704367937 1 Like on Twitter 1776037066704367937 5 Twitter 1776037066704367937

SOLACI @solaci3 ·

▶ ¡Solo quedan 2 días para el cierre del Call4science del SOLACI-CACI 2024!
▶ Presente su trabajo y comparta sus conocimientos con los más importantes expertos de la cardiología intervencionista del continente
¡No se quede afuera!
https://buff.ly/3U1XXhd

Reply on Twitter 1775957609679331784 Retweet on Twitter 1775957609679331784 Like on Twitter 1775957609679331784 5 Twitter 1775957609679331784

SOLACI @solaci3 ·

▶ Nuevo artículo en https://solaci.org
▶ Paclitaxel y mortalidad en vascular periférico: ¿Debate cerrado?
▶ Por el Dr. @tupayachi_omar
https://buff.ly/3J4OUpt

Reply on Twitter 1775674146640298049 Retweet on Twitter 1775674146640298049 1 Like on Twitter 1775674146640298049 3 Twitter 1775674146640298049

SOLACI @solaci3 ·

▶ ¡Solo 3 días para el cierre del Call4science SOLACI-CACI 2024!
🕐 Aún tiene tiempo para enviar su trabajo y ser parte del evento de cardiología intervencionista más grande de América Latina.
✅ ¡Importantes premios para los ganadores!
https://buff.ly/3TLPtcv

Reply on Twitter 1775625278410137801 Retweet on Twitter 1775625278410137801 1 Like on Twitter 1775625278410137801 1 Twitter 1775625278410137801

SOLACI
Day 4
EVOLVE II TRIAL: SYNERGY everolimus-eluting stent is not inferior to Promus Element

What is SOLACI?
About us
Bylaws
Editorial Board
Affiliated Countries
Institutional News

Become a member
Professionals Directory

SOLACI Congresses
International Congresses

About Regional Sessions
Presentations

About ProEducar
ProEducar Educational Newsletter
News

Publications
Nurses and Technicians
Patients

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 49547173 ·info@solaci.org -solaci.org -Términos de uso -Políticas de privacidad

SOLACI Latin American Society of Interventional Cardiology · Copyright © 2024. All rights reserved.

Top